About this trial
The overarching goal of our work is to test the effect of high-quality spiritual care for ICU family surrogates on outcomes of psychological and spiritual well-being and medical decision making. Our team has developed an approach to high quality spiritual care intervention for ICU surrogates, called the Spiritual Care Assessment and Intervention (SCAI) framework, which is delivered by a chaplain interventionist to ICU surrogates.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
They are age 18 or older at the time of screening.
They are age 18 or older,
They are considered the legally authorized representative (LAR) based on prior appointment by the patient or each state's medical consent law.
They are being discharged from the ICU within 24 hours.
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Spiritual Care Assessment and Intervention (SCAI) Framework
BehavioralThe SCAI intervention includes three visits generally scheduled 48-72 hours apart. After three visits, the chaplain will contact the surrogate at least weekly for the remainder of the hospitalization. If the patient dies, the chaplain will conduct a bereavement visit. The SCAI framework addresses four dimensions of spirituality. If all four dimensions are not addressed, they may be assessed during follow-up visits. If all four dimensions are addressed during the initial visit, other visits include at least one question from any dimension. The SCAI framework includes a list of common spiritual care interventions developed based on clinical experience and literature review.. Based on our conceptual framework, interventions are either are emotionally supportive, address spiritual or religious dimensions of care, or address information support such as exploring the meaning of medical events. Consistent with chaplain standards, the chaplain selects and tailors these interventions.
ICU Guide
BehavioralThe ICU Guide intervention will include three visits with the site RA that are similar in duration to the chaplain visits (based on the single center study, first visit median of 23 minutes, follow-up visit median 12 minutes), with review of a brochure introducing the family member to the ICU including staff, policies and procedures that will be helpful to the family member.
Treatment groups
Trial outcomes
Primary outcomes
Effect of the intervention on surrogate anxiety (GAD-7)
Generalized Anxiety Disorder- 7 (GAD-7) (7 item inventory of anxiety)- assesses subject's self-reported anxiety for the last two weeks. Scores range from 0-21 0= 'Not at all'; 1= 'Several Days'; 2= 'More than half the days'; 3= 'Nearly every day' Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater. Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for GAD.
Secondary outcomes
Effect of the intervention on surrogate spiritual well-being (FACIT-Sp)
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT- Sp) Scale, a 12-item questionnaire used to measure spiritual well-being in people with chronic illnesses. It assesses aspects like meaning, peace, and faith, and is widely used in research and clinical settings, particularly for patients with cancer and other serious health conditions.
Decision making quality (FS-ICU)
Family Satisfaction with the ICU Process of Decision Making Subscale, a 4 item inventory of decision making quality
Satisfaction with Spiritual Care (PSI-C)
Patient Satisfaction Instrument- Chaplaincy includes 23 clinical statements which are rated on a 4 (strongly agree) to 1 (strongly disagree) scale.
Other outcomes
Hospice enrollment
Total count of patients in both groups who enroll in hospice during the hospitalization
ICU length of stay
Total length of stay for patients in both groups
DNR declaration
Total count of patients in both groups who changed their code status to DNR during the hospitalization
Comfort plan initiation
Total count of patients in both groups who initiated a comfort plan during the hospitalization
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Indiana University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator
Regenstrief Institute, Inc.
Collaborator
University of California, San Francisco
Collaborator
Wake Forest University
Collaborator
Rush University
Collaborator
Oregon Health and Science University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: